Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sleep therapy may curb teen suicide risk

NCT ID NCT05390918

Symptom relief Sponsor: Jeff Bridge Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program called TAILOR, which uses sleep-focused therapy to help teens with insomnia who are also having suicidal thoughts. The goal is to see if improving sleep can lower their risk of suicidal behavior. The study will enroll 235 teens aged 11-18 and track changes in sleep and suicidal thoughts over 4 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
TAILOR (behavioral therapy combining cognitive behavioral therapy for insomnia and motivational interviewing)
What this could lead to
If successful, this program could offer a new way to lower suicide risk in teens by treating sleep problems.
What could go wrong
This is an early-stage trial with no prior large-scale results. The intervention is behavioral, so effects may vary. It also excludes teens with recent suicide attempts or certain mental health conditions, limiting generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 235 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2022

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

11 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion: * Nationwide Children's Hospital patients * Between the ages of 11 years, 0 months, and 18 years, 11 months, inclusive at time of consent * Endorse both recent (past 90 days) suicidal ideation and sleep problems (past 30 days) * Resides with primary caregiver who has legal authority to consent to research participation Exclusion: * Suicide attempt in the past 3 months * Diagnosis of Bipolar Disorder or Psychosis * Having a change to an antipsychotic and/or mood stabilizer medication regimen within the last 2 months * Snoring at least 3 nights per week that can be heard a room or two away, even without a cold or flu or during allergy season * Gasping for air while sleeping, diagnosis of Obstructive Sleep Apnea, or turning blue within the past year * Body Mass Index \> 40 * Daytime symptoms of Restless Leg Syndrome * Diagnosis of Narcolepsy * Diagnosis of Seizures or Epilepsy, or prescribed anticonvulsant medication, within the past 4 years * Significant substance use in the past month * Currently receiving sleep disorder services from a sleep clinic * Inability to speak/read English adequately to understand and complete study consent and procedures * No access to a telephone or internet-connecting device * Sibling already in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia Suicidal Ideation Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insomnia Suicidal ideation Suicide, attempted

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nationwide Children's Hospital

    RECRUITING

    Columbus, Ohio, 43205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.